LS Investment Advisors’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,034
| Closed | -$219K | – | 908 |
|
|
2020
Q4 | $219K | Buy |
+3,034
| New | +$159K | 0.01% | 784 |
|
|
2020
Q3 | – | Sell |
-1,214
| Closed | -$55K | – | 1625 |
|
|
2020
Q2 | $55K | Buy |
1,214
+108
| +10% | +$4.84K | ﹤0.01% | 1152 |
|
|
2020
Q1 | $43K | Hold |
1,106
| – | – | ﹤0.01% | 1150 |
|
|
2019
Q4 | $51K | Sell |
1,106
-663
| -37% | -$28.7K | ﹤0.01% | 1311 |
|
|
2019
Q3 | $72K | Hold |
1,769
| – | – | ﹤0.01% | 1187 |
|
|
2019
Q2 | $85K | Hold |
1,769
| – | – | 0.01% | 1140 |
|
|
2019
Q1 | $111K | Buy |
1,769
+40
| +2% | +$2.75K | 0.01% | 1049 |
|
|
2018
Q4 | $103K | Sell |
1,729
-4,863
| -74% | -$292K | 0.01% | 1034 |
|
|
2018
Q3 | $425K | Sell |
6,592
-1,648
| -20% | -$92K | 0.02% | 563 |
|
|
2018
Q2 | $371K | Buy |
8,240
+67
| +0.8% | +$2.67K | 0.02% | 616 |
|
|
2018
Q1 | $254K | Sell |
8,173
-115
| -1% | -$3.78K | 0.02% | 750 |
|
|
2017
Q4 | $248K | Sell |
8,288
-1,797
| -18% | -$52K | 0.01% | 788 |
|
|
2017
Q3 | $333K | Buy |
10,085
+2,783
| +38% | +$96.4K | 0.02% | 715 |
|
|
2017
Q2 | $244K | Sell |
7,302
-83
| -1% | -$2.48K | 0.01% | 820 |
|
|
2017
Q1 | $214K | Buy |
7,385
+6,205
| +526% | +$154K | 0.01% | 824 |
|
|
2016
Q4 | $26K | Hold |
1,180
| – | – | ﹤0.01% | 1495 |
|
|
2016
Q3 | $22K | Buy |
+1,180
| New | +$22.3K | ﹤0.01% | 1496 |
|
Other funds holding BEAT
LS Investment Advisors's BEAT Position: Q1 2021 in Review
LS Investment Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,034 shares — an estimated $219K sold.
LS Investment Advisors first reported a position in BEAT in Q3 2016 and held it in 17 quarters. The position peaked at $425K in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- LS Investment Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- LS Investment Advisors sold 3,034 BioTelemetry, Inc. shares in Q1 2021, an estimated $219K.
- LS Investment Advisors first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 17 quarters.
- LS Investment Advisors's BioTelemetry, Inc. position peaked at $425K in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on LS Investment Advisors's 13F filing for Q1 2021, filed 13 May 2021.